Igor L Davydkin (I L Davydkin)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

Terapevticheskii arkhiv

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Dmitrievich Kulagin, Vadim V Ptushkin, Elena A Lukina, Igor L Davydkin, Alexander V Korobkin, Vladimir S Shamrai, Tatyana S Konstantinova, Tatyana S Kaporskaya, Tatyana A Mitina, Tatyana I Ksenzova, Evgeny V Zuev, Oksana A Markova, Elena V Gapchenko, Dmitry Anatolievich Kudlay
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab. Annals of hematology 100 (11) (2021)
I A Zolotovskaya, P R Shatskaia, Igor L Davydkin, O A Shavlovskaya
[Post-COVID-19 asthenic syndrome]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (4) (2021)
Alexander Dmitrievich Kulagin, Bulat A Bakirov, Igor L Davydkin, I V Elykomov, Tatyana S Konstantinova, Alexander V Korobkin, M V Kosinova, Vadim I Mazurov, N V Minaeva, A V Proidakov, Vadim V Ptushkin, Y V Shatokhin, Yulia N Linkova, Arina V Zinkina-Orikhan, Maria A Morozova
[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial]. Terapevticheskii arkhiv 93 (11) (2021)
A M Osadchuk, Igor L Davydkin, T A Gricenko, M A Osadchuk
[General and particular issues of etiopathogenesis of peptic ulcer and gastric cancer: current status of the problem]. Terapevticheskii arkhiv 92 (2) (2020)
I A Zolotovskaya, Igor L Davydkin
[Antiresorptive-cytokine effects of the chondroprotective therapy in patients with lower back pain]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 120 (4) (2020)
Vadim V Ptushkin, Alexander Dmitrievich Kulagin, Elena A Lukina, Igor L Davydkin, Tatyana S Konstantinova, Vladimir S Shamrai, N V Minaeva, Dmitry Anatolievich Kudlay, Elena V Gapchenko, Oksana A Markova, A Y Borozinets
[Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy]. Terapevticheskii arkhiv 92 (7) (2020)